Programmed death‐ligand 1 expression in Epstein‐Barr virus positive nasopharyngeal cancer

Programmed death‐ligand 1 expression in Epstein‐Barr virus positive nasopharyngeal cancer

Abstract Nasopharyngeal cancer (NPC) is common in Saudi Arabia; Most cases are related to the Epstein‐Barr virus (EBV), which is associated with treatment failure and a high recurrence rate. Programmed cell death protein 1 (PD‐1) and Programmed death‐ligand 1 (PD‐L1) inhibitors emerged as breakthrou...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Abdulhameed Alfagih, Muhammad Amin Ur Rahman, Sadeq Al‐Dandan, Salem Alrehaili, Tariq Wani, Abdulrahim Al Malki, Ali Al Zahrani, Hatoon Bakhribah
Materialtyp: Artikel
Språk:English
Publicerad: Wiley 2023-06-01
Serie:ImmunoMedicine
Ämnen:
EBV
immunotherapy
nasopharyngeal cancer
PD‐L1 expression
Länkar:https://doi.org/10.1002/imed.1042

Internet

https://doi.org/10.1002/imed.1042

Liknande verk